AzTrials
AzTrials

HIV InfectionsPhase 2/3NCT00183573

HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic

A Phase 2/3 study testing Brief Motivational Intervention, Brief Informational Intervention and Intensive Informational Intervention in people with HIV Infections and Sexually Transmitted Diseases, run by The Miriam Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will determine the effectiveness of a two-step HIV prevention program in reducing risky sexual practices and decreasing the incidence of sexually transmitted diseases (STDs). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
HIV Infections, Sexually Transmitted Diseases
What is being tested?
Brief Motivational Intervention, Brief Informational Intervention and Intensive Informational Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,554 participants
Where
1 siteUnited States
Study dates
Mar 2004to Jul 2007
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Diagnosis or symptoms of an STD within 3 months prior to study entry OR have had unprotected vaginal or anal intercourse with one or more of the following: two or more sexual partners, a partner with two or more partners, an anonymous partner, an injection drug-using partner, or a partner with an STD
  • Able to understand English

Who cannot join

  • Psychosis or impaired mental status that would prevent participant from providing informed consent
  • Have been tested for HIV within 3 months prior to study entry
  • HIV infected

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Syracuse University

    Syracuse, New York, 13244

Other trials in United States

About this study

Official title: HIV Prevention for STD Clinic Patients

This study will determine the effectiveness of a two-step HIV prevention program in reducing risky sexual practices and decreasing the incidence of sexually transmitted diseases (STDs).

Read the detailed description

Numerous factors influence one's sexual choices, including social support and pressure, internal feelings and beliefs, and knowledge about the subject. Data indicate that people who are well-informed about the risks associated with certain sexual behaviors are more likely to protect themselves than those who are less informed. This study will determine whether an intervention comprising information, motivation, and behavioral skills components is more effective than an information-only workshop in changing sexual behavior for HIV prevention.

At study entry, participants will undergo a physical exam, various STD tests, and a rapid HIV test, which can provide test results within several hours. While waiting for their test results at the study clinic, participants will complete a computerized questionnaire assessing their thoughts, feelings, and behaviors regarding sexual activities. Participants will also be exposed to one of two brief health promotion interventions: a motivational, one-on-one counseling session or a DVD on safer sex. After receiving their test results, participants will be asked to complete a brief postassessment questionnaire about their attitudes toward their test results and the intervention.

Two-thirds of the participants will then be invited to attend an intensive, 4-hour safer sex workshop. These participants will be randomly assigned to one of two workshops: an information-only workshop or a workshop that includes information, motivation, and behavioral skills components. Participants who choose not to participate in the workshop will complete the study after receiving their STD and HIV test results. Participants who participate in the workshop will return to the clinic at 3, 6, and 12 months after the workshop to complete another questionnaire about sexual behaviors and give a urine sample for STD testing.

Being tested
Brief Motivational Intervention, Brief Informational Intervention, Intensive Informational Intervention, Intensive Info-Motivation-Behavioral Skills Intervention
Keywords
STDs, Sexual Behavior, Health Behavior, HIV Seronegativity
Medical subject headings
HIV Infections, Sexually Transmitted Diseases, Sexual Behavior, Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief Motivational InterventionBehavioural

    15-20 minute, motivational one-on-one counseling

  • Brief Informational InterventionBehavioural

    15 minute informational DVD on safer sex

  • Intensive Informational InterventionBehavioural

    4-hour, information-only intensive group workshop

  • Intensive Info-Motivation-Behavioral Skills InterventionBehavioural

    4-hour, intensive group workshop with emphasis on motivation and skills

Study groups in NCT00183573
Study groupRoleWhat they receive
1ExperimentalBrief Motivational Intervention only
Receives: Behavioral: Brief Motivational Intervention
2ExperimentalBrief Informational Intervention only
Receives: Behavioral: Brief Informational Intervention
3ExperimentalBrief Motivational Intervention + Intensive Informational Intervention
Receives: Behavioral: Brief Motivational Intervention; Behavioral: Intensive Informational Intervention
4ExperimentalBrief Motivational Intervention + Intensive Information-Motivation-Behavioral Skills Intervention
Receives: Behavioral: Brief Motivational Intervention; Behavioral: Intensive Info-Motivation-Behavioral Skills Intervention
5ExperimentalBrief Informational Intervention + Intensive Informational Intervention
Receives: Behavioral: Brief Informational Intervention; Behavioral: Intensive Informational Intervention
6ExperimentalBrief Informational Intervention + Intensive Information-Motivation-Behavioral Skills Intervention
Receives: Behavioral: Brief Informational Intervention; Behavioral: Intensive Info-Motivation-Behavioral Skills Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sexual behavior

    Measured: 12 months

Secondary outcomes (1)
  1. STD incidence

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2005 (estimated)
  2. Study startMar 2004
  3. Primary completionJul 2007
  4. Study completionJul 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,554 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00183573
Sponsor's protocol ID
R01MH068171
Other IDs
R01MH068171
Status last verified
Jun 2013
First submitted
13 Sep 2005
Last updated
7 Jun 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Brief Motivational Intervention, Brief Informational Intervention and Intensive Informational Intervention in people with HIV Infections and Sexually Transmitted Diseases, run by The Miriam Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sexual behavior (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in